Contractile capacity of fibroblasts from different sources in the model of living skin equivalent

E. Shvetsova,O. Rogovaya,S. Tkachenko,I. V. Kiselev,A. V. Vasil’ev,V. Terskikh

DOI: https://doi.org/10.1134/S1062359008020088

2008-03-01

Biology Bulletin

Abstract:

What problem does this paper attempt to address?

Continuous in vivo culture and indirect fluorescent antibody test for zoonotic protozoa of Babesia microti.

A. Saito‐Ito,Atsuko Kawai,S. Ohmori,M. Nagano‐Fujii

DOI: https://doi.org/10.1016/j.parint.2016.03.007

IF: 2.106

2016-10-01

Parasitology International

Abstract:
Localization of a novel X-linked congenital stationary night blindness locus: close linkage to the RP3 type retinitis pigmentosa gene region.

A. Bergen,J. T. ten Brink,F. Riemslag,E. Schuurman,N. Tijmes

DOI: https://doi.org/10.1093/HMG/4.5.931

IF: 5.1214

1995-05-01

Human Molecular Genetics

Abstract:X-linked congenital stationary night blindness (CSNBX) is a non-progressive retinal disorder characterized by decreased visual acuity and loss of night vision. CSNBX is clinically heterogeneous with respect to the involvement of retinal rods and/or cones in the disease. In this study, we localize a new locus for CSNBX to Xp21.1, thus providing evidence that CSNBX is also genetically heterogeneous. A clear correlation between different genotypes and phenotypes cannot be found yet. The new CSNBX gene described here is closely linked to the X-linked retinitis pigmentosa type 3 gene region, which supports the hypothesis that there may be a functional relationship between congenital stationary night blindness and retinitis pigmentosa.
Butyrate Attenuates Intestinal Inflammation in Crohn’s Disease by Suppressing Pyroptosis of Intestinal Epithelial Cells Via the Cgsa-Sting-nlrp3 Axis

Xiaofang Xu,Zhou Huang,Zhixi Huang,Xiaodan Lv,Dan Jiang,Ziqian Huang,Bing Han,Guangfu Lin,Gengfeng Liu,Shiquan Li,Junhua Fan,Xiaoping Lv

DOI: https://doi.org/10.1016/j.intimp.2024.113305

IF: 5.714

2024-01-01

International Immunopharmacology

Abstract:Butyrate can strengthen the intestinal epithelial barrier. However, the mechanisms by which butyrate affects intestinal epithelial cells (IECs) pyroptosis in Crohn's disease (CD) remain unclear. In this study, we collected colonic biopsy samples from CD patients and healthy controls to assess pyroptosis levels. Our findings indicated elevated expression of pyroptosis markers in CD patients, alongside distinct morphological evidence of pyroptosis in IECs. We further investigated the effects of tributyrin on pyroptosis and the cGAS-STING pathway in a trinitrobenzene sulfonic acid-induced colitis rat model. Tributyrin significantly mitigated intestinal inflammation, reduced pathological progression, and inhibited pyroptosis and cGAS-STING pathway activation in the colitis rat model. Similarly, in an in vitro model of IECs pyroptosis, sodium butyrate inhibited pyroptosis and cGAS-STING pathway activation in HT-29 cells. Co-treatment with a cGAS-STING pathway activator and butyrate demonstrated that the activator reversed the inhibitory effects of butyrate on pyroptosis and cGAS-STING pathway activation in both the colitis rat model and HT-29 cells. Mechanistically, the cGAS-STING pathway was found to interact with NLRP3. Taken together, butyrate may mitigate intestinal inflammation in CD by suppressing cGAS-STING-NLRP3 axis-mediated IECs pyroptosis. These findings offer new insights into potential therapeutic strategies for managing CD.
Safe handling of vaccines.

D. Casto,P. Brunell

DOI: https://doi.org/10.1542/peds.87.1.108

1991-01-01

PEDIATRICS

Abstract:The development of safe and effective vaccines for the prevention of infectious diseases associated with high mortality or morbidity is among the most significant accomplishments in medicine. The ultimate goal of eradication of a disease through immunization is an elusive one, having been achieved for only one disease—smallpox. However, a significant reduction in the number of childhood cases of diphtheria, tetanus, pertussis, poliomyelitis, measles, mumps, and rubella has been realized through the use of modern immunizing agents. Recent introduction of vaccines for the prevention of invasive disease caused by Haemophilus influenzae will hopefully provide similar results in the near future. The success of a vaccine in preventing disease is dependent on both the quality of the immunizing agent and the degree to which it is utilized. Obviously, the safest and most effective vaccine in the world will contribute nothing to the decline of a disease without clinicians' efforts to immunize at-risk individuals and without a willingness on the part of these at-risk individuals (or their parents) to receive the vaccine. This critical issue of vaccine utilization deservingly receives attention in the medical literature with some frequency.1,2 Similarly, the quality of vaccines is frequently addressed in publications concerning aspects such as reactogenicity, immunogenicity, and overall efficacy.3-6 One important factor that can influence efficacy, however, is rarely discussed—how vaccines are handled during shipment and storage. Discussions concerning preservation of vaccine potency through proper storage and maintenance of the "cold chain" may seem more pertinent to developing countries of the world, where refrigeration is not readily available and exposure of stored product to extreme environmental conditions can be expected.7-9
Isolation of Cellulolytic Microfungi Involved in Wood-WasteDecomposition: Prospects for Enzymatic Hydrolysis ofCellulosic Wastes

Shalom Nwodo Chinedu,V. Okochi,H. A. Smith,O. Omidiji

2005-09-30

Abstract:Wood-wastes from dump-sites at Okobaba Saw-mills on the western part of the Lagos lagoon were examined for cellulolytic microorganisms. Cellulolytic microfungi were isolated from the wastes using minimal salt agar medium containing 0.2% (w/v) crystalline cellulose, sugarcane pulp, corn cob or saw-dust as sole carbon/energy source. The colonies of cellulolytic microfungi which appeared on the plates increased in size and number as the incubation period (days) increased. Among the fungal isolates were two pathogenic Aspergilli (A flavus and A fumigatus), three different black Aspergilli (herein designated as A.niger I, A.niger II and A.niger III), Botrytis cinerea, Fusarium species and Penicillium species. Cell-free filtrates of 7 – day cultures of A.flavus, A.niger I, A.niger II, B. cinerea and P.species grown on the minimal salt broth supplemented with crystalline cellulose as sole carbon/energy source showed very significant CM–cellulase activity. P. species gave a very high value that was over 4 times the value for the closest organism, A.niger II. There is a good propect for cellulase production using the virgin strain of P. species isolated from the wood-wastes.
Short‐chain Fatty Acids Regulate B Cells Differentiation Via the FFA2 Receptor to Alleviate Rheumatoid Arthritis

Yao,Xiaoyu Cai,Yongquan Zheng,Meng Zhang,Weidong Fei,Dongli Sun,Mengdan Zhao,Yiqing Ye,Caihong Zheng

DOI: https://doi.org/10.1111/bph.15852

IF: 7.3

2022-01-01

British Journal of Pharmacology

Abstract:Background and PurposeShort‐chain fatty acids (SCFAs) are metabolites from gut microbes involved in the host's inflammatory response and immunity. The aim of this study was to investigate the role of SCFAs in rheumatoid arthritis (RA) and possible mechanisms.Experimental ApproachGut microbiota diversity in mice was analysed by 16S rDNA sequencing. SCFAs levels were analysed by gas chromatography mass spectrometry. T and B cells were analysed by flow cytometry. Bone damage was analysed by micro‐CT and X‐ray. Histopathological status was analysed by HE staining. Proteins in tissues were analysed by immunohistochemistry and PCR. Mice with CD19+ B cells deficient in FFA2 receptors were used to explore the molecular mechanisms involved.Key ResultsLevels of acetate, propionate, butyrate, and valerate were decreased in RA patients, and the first three correlated positively with the frequency of Bregs but not Tregs in peripheral blood. Administration of the three SCFAs prior to the onset of collagen‐induced arthritis in mice improved arthritic symptoms, increased the Bregs frequency, and decreased transitional B and follicular B cell frequency. However, the preceding phenomena could not be observed in mice with CD19+ B cells deficient in FFA2 receptors. The effects of the three SCFAs in RA were dependent on FFA2 receptors but were independent of the other five B cell receptors (FFA3 receptor, HCA2 receptor, PPARγ, Olfr‐78, and AhR).Conclusions and ImplicationsSCFAs regulate B cells differentiation via FFA2 receptors to alleviate RA. This provides new insights into the treatment of RA from an immunological and microbiological perspective.
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer

Maik Luu,Zeno Riester,Adrian Baldrich,Nicole Reichardt,Samantha Yuille,Alessandro Busetti,Matthias Klein,Anne Wempe,Hanna Leister,Hartmann Raifer,Felix Picard,Khalid Muhammad,Kim Ohl,Rossana Romero,Florence Fischer,Christian A. Bauer,Magdalena Huber,Thomas M. Gress,Matthias Lauth,Sophia Danhof,Tobias Bopp,Thomas Nerreter,Imke E. Mulder,Ulrich Steinhoff,Michael Hudecek,Alexander Visekruna

DOI: https://doi.org/10.1038/s41467-021-24331-1

IF: 16.6

2021-07-01

Nature Communications

Abstract:Abstract Emerging data demonstrate that the activity of immune cells can be modulated by microbial molecules. Here, we show that the short-chain fatty acids (SCFAs) pentanoate and butyrate enhance the anti-tumor activity of cytotoxic T lymphocytes (CTLs) and chimeric antigen receptor (CAR) T cells through metabolic and epigenetic reprograming. We show that in vitro treatment of CTLs and CAR T cells with pentanoate and butyrate increases the function of mTOR as a central cellular metabolic sensor, and inhibits class I histone deacetylase activity. This reprogramming results in elevated production of effector molecules such as CD25, IFN-γ and TNF-α, and significantly enhances the anti-tumor activity of antigen-specific CTLs and ROR1-targeting CAR T cells in syngeneic murine melanoma and pancreatic cancer models. Our data shed light onto microbial molecules that may be used for enhancing cellular anti-tumor immunity. Collectively, we identify pentanoate and butyrate as two SCFAs with therapeutic utility in the context of cellular cancer immunotherapy.

multidisciplinary sciences
Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI‐mediated signaling

Jelle Folkerts,Frank Redegeld,Gert Folkerts,Bart Blokhuis,Mariska P. M. Berg,Marjolein J. W. Bruijn,Wilfred F. J. IJcken,Tobias Junt,See‐Ying Tam,Stephen J. Galli,Rudi W. Hendriks,Ralph Stadhouders,Marcus Maurer

DOI: https://doi.org/10.1111/all.14254

IF: 12.4

2020-04-24

Allergy

Abstract:BackgroundShort‐chain fatty acids (SCFAs) are fermented dietary components that regulate immune responses, promote colonic health and suppress mast cell‐mediated diseases. However, the effects of SCFAs on human mast cell function, including the underlying mechanisms, remain unclear. Here, we investigated the effects of the SCFAs acetate, propionate and butyrate on mast cell‐mediated pathology and human mast cell activation, including the molecular mechanisms involved. MethodPrecision‐cut lung slices (PCLS) of allergen‐exposed guinea pigs were used to assess the effects of butyrate on allergic airway contraction. Human and mouse mast cells were co‐cultured with SCFAs and assessed for degranulation after IgE‐ or non‐IgE‐mediated stimulation. The underlying mechanisms involved were investigated using knockout mice, small molecule inhibitors/agonists, and genomics assays. ResultsButyrate treatment inhibited allergen‐induced histamine release and airway contraction in guinea pig PCLS. Propionate and butyrate, but not acetate, inhibited IgE and non‐IgE‐mediated human or mouse mast cell degranulation in a concentration‐dependent manner. Notably, these effects were independent of the stimulation of SCFA receptors GPR41, GPR43 or PPAR, but instead were associated with inhibition of histone deacetylases. Transcriptome analyses revealed butyrate‐induced downregulation of the tyrosine kinases BTK, SYK and LAT, critical transducers of FcεRI‐mediated signals that are essential for mast cell activation. Epigenome analyses indicated that butyrate redistributed global histone acetylation in human mast cells, including significantly decreased acetylation at the BTK, SYK and LAT promoter regions. ConclusionKnown health benefits of SCFAs in allergic disease can, at least in part, be explained by epigenetic suppression of human mast cell activation.

immunology,allergy
[In-vitro cancer cell growth regulation by fibroblasts, with special reference to the relationship with fibroblast aging].

S. Kagawa

1984-11-20

Abstract:
, Dogs in Switzerland Canine Granulocytic Ehrlichia Infection in and of Ehrlichia canis Seroprevalence of

N. Pusterla,J. B. Pusterla,P. Deplazes,C. Wolfensberger,W. Müller,A. Hörauf,C. Reusch,H. Lutz

Abstract:
Butyrate Prevents the Pathogenic Anemia‐Inflammation Circuit by Facilitating Macrophage Iron Export

Peng Xiao,Xuechun Cai,Zhou Zhang,Ke Guo,Yuehai Ke,Ziwei Hu,Zhangfa Song,Yuening Zhao,Lingya Yao,Manlu Shen,Jingyun Li,Youling Huang,Lingna Ye,Lingjie Huang,Yu Zhang,Rongbei Liu,Mengque Xu,Xutao Xu,Yuan Zhao,Qian Cao

DOI: https://doi.org/10.1002/advs.202306571

IF: 15.1

2024-01-01

Advanced Science

Abstract:Most patients with inflammatory bowel disease (IBD) develop anemia, which is attributed to the dysregulation of iron metabolism. Reciprocally, impaired iron homeostasis also aggravates inflammation. How this iron-mediated, pathogenic anemia-inflammation crosstalk is regulated in the gut remains elusive. Herein, it is for the first time revealed that anemic IBD patients exhibit impaired production of short-chain fatty acids (SCFAs), particularly butyrate. Butyrate supplementation restores iron metabolism in multiple anemia models. Mechanistically, butyrate upregulates ferroportin (FPN) expression in macrophages by reducing the enrichment of histone deacetylase (HDAC) at the Slc40a1 promoter, thereby facilitating iron export. By preventing iron sequestration, butyrate not only mitigates colitis-induced anemia but also reduces TNF-α production in macrophages. Consistently, macrophage-conditional FPN knockout mice exhibit more severe anemia and inflammation. Finally, it is revealed that macrophage iron overload impairs the therapeutic effectiveness of anti-TNF-α antibodies in colitis, which can be reversed by butyrate supplementation. Hence, this study uncovers the pivotal role of butyrate in preventing the pathogenic circuit between anemia and inflammation.
Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition

Sandra G P J Korsten,Laura Peracic,Luka M B van Groeningen,Mara A P Diks,Herman Vromans,Johan Garssen,Linette E M Willemsen

DOI: https://doi.org/10.3390/ijms23073980

2022-04-02

Abstract:Non-communicable diseases are increasing and have an underlying low-grade inflammation in common, which may affect gut health. To maintain intestinal homeostasis, unwanted epithelial activation needs to be avoided. This study compared the efficacy of butyrate, propionate and acetate to suppress IFN-γ+/-TNF-α induced intestinal epithelial activation in association with their HDAC inhibitory capacity, while studying the canonical and non-canonical STAT1 pathway. HT-29 were activated with IFN-γ+/-TNF-α and treated with short chain fatty acids (SCFAs) or histone deacetylase (HDAC) inhibitors. CXCL10 release and protein and mRNA expression of proteins involved in the STAT1 pathway were determined. All SCFAs dose-dependently inhibited CXCL10 release of the cells after activation with IFN-γ or IFN-γ+TNF-α. Butyrate was the most effective, completely preventing CXCL10 induction. Butyrate did not affect phosphorylated STAT1, nor phosphorylated NFκB p65, but inhibited IRF9 and phosphorylated JAK2 protein expression in activated cells. Additionally, butyrate inhibited CXCL10, SOCS1, JAK2 and IRF9 mRNA in activated cells. The effect of butyrate was mimicked by class I HDAC inhibitors and a general HDAC inhibitor Trichostatin A. Butyrate is the most potent inhibitor of CXCL10 release compared to other SCFAs and acts via HDAC inhibition. This causes downregulation of CXCL10, JAK2 and IRF9 genes, resulting in a decreased IRF9 protein expression which inhibits the non-canonical pathway and CXCL10 transcription.
Microbial metabolite butyrate promotes induction of IL-10+IgM+ plasma cells

Bandik Föh,Jana Sophia Buhre,Hanna B. Lunding,Maria E. Moreno-Fernandez,Peter König,Christian Sina,Senad Divanovic,Marc Ehlers

DOI: https://doi.org/10.1371/journal.pone.0266071

IF: 3.7

2022-03-25

PLoS ONE

Abstract:The microbially-derived short-chain fatty acid butyrate is a central inhibitor of inflammatory innate and adaptive immune responses. Emerging evidence suggests that butyrate induces differentiation of IL-10-producing (IL-10 + ) regulatory B cells. However, the underlying mechanisms of butyrate-driven modulation of B cell differentiation are not fully defined. Given the dominant role of regulatory plasma cells (PCs) as the main source of anti-inflammatory cytokines including IL-10 and the observation that butyrate also induces the differentiation of PCs, we here investigated the effect of the microbial metabolite butyrate on the induction of regulatory IL-10 + PCs and underlying mechanisms. Here we show that butyrate induces the differentiation of IL-10 + IgM + PCs. Ex vivo , butyrate, but hardly propionate, another microbially-derived short-chain fatty acid, induced the differentiation of IL-10 + IgM + CD138 high PCs from isolated splenic murine B cells. In vivo , administration of butyrate via drinking water or by daily intraperitoneal injection increased the number of IL-10 + IgM + CD138 high PCs in the spleens of Ovalbumin (Ova)/complete Freund’s adjuvant-immunized mice. The induction of these regulatory PCs was associated with an increase of anti-Ova IgM, but a reduction of anti-Ova class-switched pathogenic IgG2b serum antibodies. Based on the knowledge that butyrate inhibits histone deacetylases (HDACs) thereby increasing histone acetylation, we identified here that HDAC3 inhibition was sufficient to induce PC differentiation and IL-10 + expression. Furthermore, reduced mitochondrial superoxide levels following butyrate treatment and HDAC3 inhibition were necessary for PC differentiation, but not IL-10 expression. In summary, the microbial metabolite butyrate promotes the differentiation of IgM + PCs and their expression of IL-10. HDAC3 inhibition may be involved as an underlying pathway for both PC differentiation and IL-10 expression, while reduced mitochondrial superoxide levels are crucial only for PC differentiation. The induction of regulatory IL-10 + IgM + PCs and the inhibition of class switching to antigen-specific pathogenic IgG subclasses might represent important pathways of butyrate to limit inflammation.

multidisciplinary sciences
New biotech hubs may emerge as industry matures

Paroma Basu

DOI: https://doi.org/10.1038/NBT884

IF: 46.9

2003-10-01

Nature Biotechnology

Abstract:
Butyrate Protects Barrier Integrity and Suppresses Immune Activation in a Caco-2/PBMC Co-Culture Model While HDAC Inhibition Mimics Butyrate in Restoring Cytokine-Induced Barrier Disruption

Sandra G P J Korsten,Herman Vromans,Johan Garssen,Linette E M Willemsen

DOI: https://doi.org/10.3390/nu15122760

IF: 5.9

2023-06-15

Nutrients

Abstract:Low-grade inflammation and barrier disruption are increasingly acknowledged for their association with non-communicable diseases (NCDs). Short chain fatty acids (SCFAs), especially butyrate, could be a potential treatment because of their combined anti-inflammatory and barrier- protective capacities, but more insight into their mechanism of action is needed. In the present study, non-activated, lipopolysaccharide-activated and αCD3/CD28-activated peripheral blood mononuclear cells (PBMCs) with and without intestinal epithelial cells (IEC) Caco-2 were used to study the effect of butyrate on barrier function, cytokine release and immune cell phenotype. A Caco-2 model was used to compare the capacities of butyrate, propionate and acetate and study their mechanism of action, while investigating the contribution of lipoxygenase (LOX), cyclooxygenase (COX) and histone deacetylase (HDAC) inhibition. Butyrate protected against inflammatory-induced barrier disruption while modulating inflammatory cytokine release by activated PBMCs (interleukin-1 beta↑, tumor necrosis factor alpha↓, interleukin-17a↓, interferon gamma↓, interleukin-10↓) and immune cell phenotype (regulatory T-cells↓, T helper 17 cells↓, T helper 1 cells↓) in the PBMC/Caco-2 co-culture model. Similar suppression of immune activation was shown in absence of IEC. Butyrate, propionate and acetate reduced inflammatory cytokine-induced IEC activation and, in particular, butyrate was capable of fully protecting against cytokine-induced epithelial permeability for a prolonged period. Different HDAC inhibitors could mimic this barrier-protective effect, showing HDAC might be involved in the mechanism of action of butyrate, whereas LOX and COX did not show involvement. These results show the importance of sufficient butyrate levels to maintain intestinal homeostasis.
Short chain fatty acids regulation of neutrophil production of IL-10

Feidi Chen,Wei Wu,Yingzi Cong

DOI: https://doi.org/10.4049/jimmunol.196.supp.207.6

2016-05-01

The Journal of Immunology

Abstract:Abstract Despite questions regarding the role of microbiota in regulation of host immune responses within the intestines, evidence suggests that in the context of disease and autoimmunity bacterial metabolites might impact the systemic immune response. Otherwise indigestible carbohydrates are metabolized into short-chain fatty acids (SCFAs) by gut bacteria. SCFAs have been shown to inhibit intestinal inflammation in experimental colitis through regulation of mucosal T cells and macrophages. Recently, neutrophils have been shown to regulate intestinal homeostasis and the pathogenesis of IBD, however, how SCFAs may regulate neutrophil function is unclear. In this study, we demonstrate that SCFA differentially regulate neutrophil cytokine production. Of the three major SCFAs butyrate, acetate, and propionate, only butyrate down-regulated neutrophil IL-10 production. We further showed that butyrate-inhibition of neutrophil IL-10 is independent of GPR43, in that butyrate also inhibited IL-10 production in GPR43 deficient neutrophils. We recently showed that IL-23 induced neutrophil production of IL-17 and IL-22 in a mTOR dependent manner; however, butyrate did not affect IL-23-induced IL-17 and IL-22 production in neutrophils. Taken together, our data indicates that microbiota metabolites differentially regulate neutrophil cytokine production.

immunology
Short-chain fatty acids stimulate dendrite elongation in dendritic cells by inhibiting histone deacetylase

Takuho Inamoto,Kazuyuki Furuta,Cheng Han,Mio Uneme,Tomonori Kano,Kazuya Ishikawa,Chikara Kaito

DOI: https://doi.org/10.1111/febs.16945

Abstract:Dendritic cells activate immune responses by presenting pathogen-derived molecules. The dendrites of dendritic cells contribute to the incorporation of foreign antigens or presenting antigens to T cells. Short-chain fatty acids (SCFAs), such as acetic, propionic, butyric and valeric acids, have many effects on immune responses by activating specific receptors or inhibiting a histone deacetylase (HDAC), although their effect on dendrite formation in dendritic cells is unknown. In the present study, we aimed to investigate the effect of SCFAs on dendrite elongation using a dendritic cell line (DC2.4 cells) and mouse bone marrow-derived dendritic cells. We found that SCFAs induced dendrite elongation. The elongation was reduced by inhibitors of Src family kinase (SFK), phosphatidylinositol-3 kinase (PI3K), Rho family GTPases (Cdc42, Rac1) or actin polymerization, indicating that SCFAs promote dendrite elongation by activating actin polymerization via the SFK/PI3K/Rho family GTPase signaling pathway. We showed that agonists for SCFA receptors GPR43 and GPR109a did not promote dendrite elongation. By contrast, HDAC inhibitors, including trichostatin A, promoted dendrite elongation in DC2.4 cells, and the promoting activity of trichostatin A was decreased by inhibiting the SFK/PI3K/Rho family GTPase signaling pathway or actin polymerization. Furthermore, DC2.4 cells treated with valeric acid showed enhanced uptake of soluble proteins, insoluble beads and Staphylococcus aureus. We also found that treatment with valeric acid enhanced major histocompatibility complex class II-mediated antigen presentation in bone marrow-derived dendritic cells. These results suggest that SCFAs promote dendrite elongation by inhibiting HDAC, stimulating the SFK/PI3K/Rho family pathway and activating actin polymerization, resulting in increased antigen uptake and presentation in dendritic cells.
B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids

Helia N. Sanchez,Justin B. Moroney,Huoqun Gan,Tian Shen,John L. Im,Tianbao Li,Julia R. Taylor,Hong Zan,Paolo Casali

DOI: https://doi.org/10.1038/s41467-019-13603-6

IF: 16.6

2020-01-02

Nature Communications

Abstract:Abstract Short-chain fatty acids (SCFAs) butyrate and propionate are metabolites from dietary fiber's fermentation by gut microbiota that can affect differentiation or functions of T cells, macrophages and dendritic cells. We show here that at low doses these SCFAs directly impact B cell intrinsic functions to moderately enhance class-switch DNA recombination (CSR), while decreasing at higher doses over a broad physiological range, AID and Blimp1 expression, CSR, somatic hypermutation and plasma cell differentiation. In human and mouse B cells, butyrate and propionate decrease B cell Aicda and Prdm1 by upregulating select miRNAs that target Aicda and Prdm1 mRNA-3′UTRs through inhibition of histone deacetylation (HDAC) of those miRNA host genes. By acting as HDAC inhibitors, not as energy substrates or through GPR-engagement signaling in these B cell-intrinsic processes, these SCFAs impair intestinal and systemic T-dependent and T-independent antibody responses. Their epigenetic impact on B cells extends to inhibition of autoantibody production and autoimmunity in mouse lupus models.

multidisciplinary sciences
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer

Clélia Coutzac,Jean-Mehdi Jouniaux,Angelo Paci,Julien Schmidt,Domenico Mallardo,Atmane Seck,Vahe Asvatourian,Lydie Cassard,Patrick Saulnier,Ludovic Lacroix,Paul-Louis Woerther,Aurore Vozy,Marie Naigeon,Laetitia Nebot-Bral,Mélanie Desbois,Ester Simeone,Christine Mateus,Lisa Boselli,Jonathan Grivel,Emilie Soularue,Patricia Lepage,Franck Carbonnel,Paolo Antonio Ascierto,Caroline Robert,Nathalie Chaput

DOI: https://doi.org/10.1038/s41467-020-16079-x

IF: 16.6

2020-05-01

Nature Communications

Abstract:Abstract Gut microbiota composition influences the clinical benefit of immune checkpoints in patients with advanced cancer but mechanisms underlying this relationship remain unclear. Molecular mechanism whereby gut microbiota influences immune responses is mainly assigned to gut microbial metabolites. Short-chain fatty acids (SCFA) are produced in large amounts in the colon through bacterial fermentation of dietary fiber. We evaluate in mice and in patients treated with anti-CTLA-4 blocking mAbs whether SCFA levels is related to clinical outcome. High blood butyrate and propionate levels are associated with resistance to CTLA-4 blockade and higher proportion of Treg cells. In mice, butyrate restrains anti-CTLA-4-induced up-regulation of CD80/CD86 on dendritic cells and ICOS on T cells, accumulation of tumor-specific T cells and memory T cells. In patients, high blood butyrate levels moderate ipilimumab-induced accumulation of memory and ICOS + CD4 + T cells and IL-2 impregnation. Altogether, these results suggest that SCFA limits anti-CTLA-4 activity.

multidisciplinary sciences
Short‐chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells

Maik Luu,Alexander Visekruna

DOI: https://doi.org/10.1002/eji.201848009

2019-05-17

European Journal of Immunology

Abstract:Short‐chain fatty acids (SCFAs) are mainly generated by bacterial fermentation of non‐digestible carbohydrates such as dietary fiber. In the last decade, new investigations have revealed that SCFAs have a very specific function and serve as active microbial metabolites, which are able to modulate the function of immune cells in the intestine and other tissues. Recent studies have highlighted the immunomodulatory potential of SCFAs in several autoimmune and inflammatory disorders such as multiple sclerosis, colitis, type 1 diabetes and rheumatoid arthritis. While the SCFA‐mediated activation of GPR41/GPR43 signalling pathways and their inhibitory activity on histone deacetylases have been extensively investigated, the impact of SCFAs on the T cell metabolism is poorly understood. SCFAs induce metabolic alterations in T cells by enhancing the activity of the mTOR complex and by regulating their glucose metabolism. Once taken up into T lymphocytes, SCFA‐derived acetyl groups contribute to the cellular acetyl‐CoA pool, which influences the histone acetylation and cytokine gene expression. This article reviews how SCFAs modulate the metabolic status of T cells, thereby impacting on epigenetic modifications and T cell function. We will also discuss how the recent findings from SCFA biology might be utilized for potential immune therapies of various autoimmune diseases.This article is protected by copyright. All rights reserved

immunology

Contractile capacity of fibroblasts from different sources in the model of living skin equivalent

Continuous in vivo culture and indirect fluorescent antibody test for zoonotic protozoa of Babesia microti.

Localization of a novel X-linked congenital stationary night blindness locus: close linkage to the RP3 type retinitis pigmentosa gene region.

Butyrate Attenuates Intestinal Inflammation in Crohn’s Disease by Suppressing Pyroptosis of Intestinal Epithelial Cells Via the Cgsa-Sting-nlrp3 Axis

Safe handling of vaccines.

Isolation of Cellulolytic Microfungi Involved in Wood-WasteDecomposition: Prospects for Enzymatic Hydrolysis ofCellulosic Wastes

Short‐chain Fatty Acids Regulate B Cells Differentiation Via the FFA2 Receptor to Alleviate Rheumatoid Arthritis

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer

Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI‐mediated signaling

[In-vitro cancer cell growth regulation by fibroblasts, with special reference to the relationship with fibroblast aging].

, Dogs in Switzerland Canine Granulocytic Ehrlichia Infection in and of Ehrlichia canis Seroprevalence of

Butyrate Prevents the Pathogenic Anemia‐Inflammation Circuit by Facilitating Macrophage Iron Export

Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition

Microbial metabolite butyrate promotes induction of IL-10+IgM+ plasma cells

New biotech hubs may emerge as industry matures

Butyrate Protects Barrier Integrity and Suppresses Immune Activation in a Caco-2/PBMC Co-Culture Model While HDAC Inhibition Mimics Butyrate in Restoring Cytokine-Induced Barrier Disruption

Short chain fatty acids regulation of neutrophil production of IL-10

Short-chain fatty acids stimulate dendrite elongation in dendritic cells by inhibiting histone deacetylase

B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids

Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer

Short‐chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells